Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.8B | 2.1B | 2.7B | 2.0B |
Cost of revenue | 1.4B | 1.7B | 2.2B | 1.6B |
Gross profit | 338.2M | 357.1M | 484.3M | 384.2M |
Operating expense | ||||
Research & development | 88.7M | 133.3M | 94.3M | 118.3M |
Selling general and admin | 142.1M | -185.6M | 328.1M | -22.6M |
Other operating expenses | 5.0M | 50.4M | 6.1M | 17.3M |
Operating income | 121.8M | 40.9M | 243.6M | 149.5M |
Non operating interest income | ||||
Income | 11.4M | 13.8M | 20.3M | 18.9M |
Expense | 16.2M | 10.2M | 13.3M | 11.1M |
Other income expense | — | — | — | — |
Pretax income | 125.8M | -3.8M | 210.8M | 152.7M |
Tax provision | 14.7M | -9.1M | 21.2M | 1.6M |
Net income | 111.1M | 5.3M | 189.6M | 151.1M |
Basic EPS | 0.2 | — | — | — |
Diluted EPS | 0.2 | — | — | — |
Basic average shares | 636.2M | — | — | — |
Diluted average shares | 636.2M | — | — | — |
EBITDA | 143.2M | 98.8M | 237.7M | 182.7M |
Net income from continuing op. | — | — | — | — |
Minority interests | -15.7M | -9.4M | -26.8M | -11.1M |
Preferred stock dividends | 0 | 0 | 0 | 0 |